What Is Veru Inc. (VERU) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Veru Inc.'s intrinsic value is estimated at a composite fair value of $2.98. While the stock appears modestly undervalued at $2.42 (implied upside of +23.2%), our analysis suggests a thinner margin of safety across 5 of 7 bullish models. Notably, Sentiment SOTP sees the most upside at +110.3% (fair value: $5.09), while ML-RIV is the most conservative at -92.9% ($0.17). The spread between these extremes — +203.2% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About VERU?
7 of 13 models are currently active for VERU. Of these, 5 models suggest upside while 2 models suggest overvaluation. The Bayesian DCF estimates VERU's intrinsic value at $1.66, implying -31.2% downside from the current price. See which stocks rank higher →
How Does VERU Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, VERU ranks #284 by Quality of Company score. CirclFi's QOC score of 4.4/10 evaluates 32 fundamental signals. A score of 4.4 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
The Pharmaceutical Preparations sector introduces analytical considerations specific to healthcare company businesses. For Veru Inc., metrics like R&D productivity ratio provide important context that general-purpose valuation models may underweight.
Is VERU a Value Trap?
CirclFi's Value Trap algorithm assigns VERU a score of 20/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
7 of 13 models are active for Veru Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Veru Inc. scores 4.4 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +203.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every VERU valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across VERU's 7 active models, average confidence is 25%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →